US EditionPublished • loading... • Updated
The new era of cancer screening: What ‘Multi-Cancer Early Detection’ really means
- Routine screening has focused on breast, cervical, colorectal, and high-risk lung cancers, leaving nearly 70% of cancer cases without recommended screening options.
- Multi-Cancer early detection testing offers a new approach to detecting cancer earlier.
- The Cancerguard® test is a blood-based MCED test that detects over 50 cancer types, including some deadly cancers like pancreatic and liver cancer, and supports other standard screenings.
- The Cancerguard test has a 97.4% specificity and requires patients to consult healthcare providers for next steps if a cancer signal is detected, as it is not a diagnosis.
Insights by Ground AI
62 Articles
62 Articles
Bennington Banner+61 Reposted by 61 other sources
The new era of cancer screening: What ‘Multi-Cancer Early Detection’ really means
(BPT) - For years, routine screening recommendations have been limited to four cancers — breast, cervical, colorectal, and high-risk lung cancer — leaving nearly 70% of annual cancer cases and deaths with no recommended screening options.1,2,3,4 This unmet need leaves…
Coverage Details
Total News Sources62
Leaning Left3Leaning Right4Center29Last UpdatedBias Distribution81% Center
Bias Distribution
- 81% of the sources are Center
81% Center
C 81%
11%
Factuality
To view factuality data please Upgrade to Premium
